City National Bank’s CASI Pharmaceuticals CASI Stock Holding History

City National Bank’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$19K	Hold	1,739	–	–	﹤0.01%	827
2015 Q2	$31K	Hold	1,739	–	–	﹤0.01%	850
2015 Q1	$26K	Hold	1,739	–	–	﹤0.01%	867
2014 Q4	$23K	Hold	1,739	–	–	﹤0.01%	855
2014 Q3	$31K	Buy	+1,739	New	+$30.9K	﹤0.01%	890
2014 Q2	–	Sell	-1,739	Closed	-$32K	–	910
2014 Q1	$32K	Hold	1,739	–	–	﹤0.01%	807
2013 Q4	$29K	Hold	1,739	–	–	﹤0.01%	832
2013 Q3	$31K	Buy	+1,739	New	+$33K	﹤0.01%	744

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

WSC

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

CWM

Concert Wealth Management San Jose, California $24.7M AUM 21.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

City National Bank's CASI Position: Q3 2015 in Review

City National Bank held its CASI Pharmaceuticals (CASI) position steady in Q3 2015 at 1,739 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #827.

City National Bank first reported a position in CASI in Q3 2013 and has held it in 8 quarters since. The position peaked at $32K in Q1 2014. 31 funds tracked by Wall St. Rank hold CASI as of Q3 2015.

City National Bank held 1,739 shares of CASI Pharmaceuticals worth $19K as of Q3 2015.
City National Bank left its CASI Pharmaceuticals share count unchanged in Q3 2015.
CASI Pharmaceuticals made up ﹤0.01% of City National Bank's portfolio in Q3 2015, its #827 holding.
City National Bank first reported a position in CASI Pharmaceuticals in Q3 2013 and has held it in 8 quarters since.
City National Bank's CASI Pharmaceuticals position peaked at $32K in Q1 2014.
31 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.